Glowczwski Alan, Hohmann Stephen, Ross John, Peden Eric, Gowda Ashok, Lovelady April, Glowczwski Justin, Fridley Jennifer, Simon Bradley T
Voyager Biomedical, Inc., Houston, TX, USA.
Veterinary Medical Park, Texas A&M University, College Station, TX, USA.
J Vasc Access. 2025 Sep;26(5):1531-1538. doi: 10.1177/11297298241286554. Epub 2024 Oct 6.
The Ark is a 3-D printed titanium device designed to be implanted around the draining vein of an arteriovenous fistula (AVF) to facilitate vascular access. The purpose of this study was to assess AVF maturation after Ark implantation in a large animal model.
End-to-side AVFs were created between the carotid artery and jugular vein in nine pygmy goats that included three control (AVF only) and six experimental (AVF and Ark device) animals. For experimental animals, an Ark device was implanted approximately 10 cm downstream of the anastomosis at the time of AVF creation. Postoperative ultrasounds and cannulations of the jugular vein fistula were performed over 12 months. At the conclusion of the study, the AVF was ligated and Ark devices along with a segment of the arterialized vein and surrounding tissues were explanted for gross and histological assessment.
The control and experimental Ark groups exhibited increased dilation and flow as well as diminished depth underscoring the parallel developments in vascular attributes and AVF maturation between the two groups. Gross pathology, histology, and micro-CT imaging revealed intact endothelium, mature tissue integration throughout the porous Ark device, and no underlying stenosis. No adverse events such as foreign body reaction, skin or vessel erosion were identified.
The study showed maturation without stenosis of the fistula in all animals. This study confirmed that the Ark device functions as a scaffold around the access vein, allows fistula maturation, and can be consistently cannulated without infiltrations over a 12-month period in a large animal model.
方舟是一种3D打印钛制装置,设计用于植入动静脉内瘘(AVF)的引流静脉周围,以促进血管通路的建立。本研究的目的是在大型动物模型中评估植入方舟后AVF的成熟情况。
在9只侏儒山羊的颈动脉和颈静脉之间建立端侧AVF,其中包括3只对照动物(仅建立AVF)和6只实验动物(建立AVF并植入方舟装置)。对于实验动物,在建立AVF时,将方舟装置植入吻合口下游约10厘米处。术后12个月内对颈静脉内瘘进行超声检查和插管。在研究结束时,结扎AVF,并将方舟装置连同一段动脉化静脉及周围组织取出,进行大体和组织学评估。
对照组和实验性方舟组均表现出扩张增加、血流增加以及深度减小,这突出了两组在血管特性和AVF成熟方面的平行发展。大体病理学、组织学和微型CT成像显示内皮完整,多孔方舟装置内组织成熟整合,且无潜在狭窄。未发现异物反应、皮肤或血管侵蚀等不良事件。
该研究表明所有动物的内瘘均成熟且无狭窄。本研究证实,方舟装置可作为通路静脉周围的支架,使内瘘成熟,并且在大型动物模型中,在12个月的时间内可以持续进行插管而不发生渗漏。